Medpace Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Medpace Holdings, Inc. announces strong 2025 financial results, exceeding guidance, and proposes key corporate governance amendments for its 2026 Annual Meeting.
NASDAQ
Medpace Holdings, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Medpace Holdings will hold its 2025 Annual Meeting of Stockholders virtually on May 16, 2025, to vote on director elections, auditor ratification, executive compensation, an incentive award plan, and a stockholder proposal.
NASDAQ
Medpace Holdings, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Medpace Holdings is seeking stockholder approval to amend its certificate of incorporation to phase out the classified board structure, aiming for full declassification by the 2027 annual meeting.